Last call order for PT/INR assays - for aurora VA, oklahoma city VA and salt lake city VA
Ended Awarded Last action
- Contract number
- 36C25924N0450
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $48,254
Award facts
- Contract value 100% obligated
- $48,254.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$77,192 | |
| Funding Only Action | $11,661 | |
| Original award | $113,785 |
About this award
Roche Diagnostics Corporation has been awarded a final call order valued at $48,254.03 under a Blanket Purchase Agreement (BPA) with the Department of Veterans Affairs' Veterans Integrated Service Network 19. This firm fixed-price order, issued on September 9, 2024, with an ultimate completion date of September 8, 2025, is for PT/INR assays to support laboratory testing operations at three VA medical facilities: Aurora VA, Oklahoma City VA, and Salt Lake City VA. The award represents a child contract under a larger pre-negotiated agreement that enables the VA to efficiently procure Roche's diagnostic products through established pricing and terms. No small business set-aside was utilized for this procurement.
Roche Diagnostics Corporation, a global manufacturer of in vitro diagnostic systems and reagents, supplies critical laboratory testing capabilities across the federal healthcare system. PT/INR assays are essential coagulation tests used to monitor patients on anticoagulant therapy and assess blood clotting function. This order fulfills specific testing needs at three geographically dispersed VA medical centers, leveraging the established BPA vehicle under which Roche provides a comprehensive range of diagnostic reagents and testing supplies to VA facilities nationwide.
Quick answers
Who was awarded contract 36C25924N0450?
36C25924N0450 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 19 (Veterans Health Administration) on September 9, 2024.
How much is contract 36C25924N0450 worth?
The government has obligated $48,254 on 36C25924N0450.
Is contract 36C25924N0450 an order under another contract?
Yes. 36C25924N0450 is a BPA call under 36C25919A0035, a blanket purchase agreement.
Was contract 36C25924N0450 competed?
The extent of competition for 36C25924N0450 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award